NovaBay Pharmaceuticals Inc (NBY) USD0.01
Sell:$0.64Buy:$0.67
$0.01
(1.76%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$0.64
Buy:$0.67
Change:$0.01
(1.76%)
$0.01
(1.76%)Prices delayed by at least 15 minutes
Sell:$0.64
Buy:$0.67
Change:$0.01
(1.76%)
$0.01
(1.76%)Prices delayed by at least 15 minutes
Company Information
About this company
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Key people
Justin M. Hall
Chief Executive Officer, Chief Compliance Officer, General Counsel
Tommy Law
Interim Chief Financial Officer, Treasurer
Paul E. Freiman
Independent Chairman of the Board
Mijia Wu
Director
Yongxiang Zheng
Director
Julie Garlikov
Independent Director
Swan Sit
Independent Director
Click to see more
Key facts
- EPIC-
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS66987P4090
- Market cap$3.25m
- Employees24
- Shares in issue4.89m
- ExchangeNyse American LLC
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.